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INTRODUCTION
MRI devices and associated technology are im-
proving and maturing rapidly. In addition, one of the
recent hot topics is the appearance of the 3 Tesla
(3T) instruments.
Though its licensing by the Japanese Government
was slower than by Western countries, it is consid-
ered that its impact on clinical diagnosis will be huge
when the high S/N ratio and effect of magnetic
susceptibility are used effectively.
In this review, the utility of the“Propeller Technique”
which is comparatively resistant to body movement
as one of the areas of progress in recent MRI
technology is introduced, and the characteristics
of 3T MRI are included concerning the develop-
ment of applying metabolic changes and functional
evaluations in the clinical diagnosis of the central
nervous system.
1. Technology born from clinical need; the clinical
utility of the Propeller Technique
The shortening of measurement time is a goal
of the recent MRI technology, and the efficient use
of not only parallel imaging but also a multi-channel
coil will shorten the measuring time drastically.
However, even if the measurement time is short-
ened using the new measurement technique, any
body movement causes a larger artifact in the
rapid MR scan due to there being less compensa-
tion for body movement than by classical MR im-
aging. Such an artifact can be especially problem-
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atic for the new technique of parallel imaging.
This decline in image quality may lead to difficulty
in diagnosis and, furthermore, artifacts may lead
to misdiagnose. Thus, any reduction of measure-
ment time will be meaningless.
So far, for unstable subjects, priority has been
given to diagnostic imaging techniques such as
CT, sedating patients when MRI was necessary.
Nowadays, the“Propeller Technique” is one method
which can be effectively applied for unstable
patients. The basic theory behind this technique
involves the gathering of much raw data on the
center in the K space in which the contrast of the
image is decided, and the Propeller Technique
can minimizes the influence of any position a de-
viations due to body movement via the integration
of adequate raw data.
When measurements cannot be completed due
to the body movement of a subject, we are now
applying this new technique in our facilities before
resorting to sedation.
A case in which the Propeller Technique was
employed in our facilities is shown in Figure 1, and
the effectiveness of this new technique could be
observed. This case had a large mass in the lateral
ventricle and was complicated by obstructive hy-
drocephalus due to the circulatory failure of the
cerebrospinal fluid caused by obsession of the
Monro foramen. CT demonstrated calcification in
the mass.
When a decline in the level of consciousness was
recognized, MRI was conducted, but there was a
large artifact on conventional T2-WI due to head
movement and the details weren’t clear. Then,
images of FLAIR and a T2-WI by the Propeller
Technique were added and adequate images which
could be used for diagnosis were acquired. The state
of cystic degeneration, which was observed as a
low intensity signal with FLAIR, could be observed,
and still a high intensity signal was thought to be
useful for the qualitative diagnosis with T2-WI of
the mass. As for the MRI diagnosis of the brain
tumor, the examination time including FLAIR
imaging and contrast enhanced T1-WI is usually
long and it is considered lucky when the examina-
tion of an unstable patient can be conducted without
sedation. It is also considered that this may greatly
benefit radiologists by reducing the number of
staff needed in the field of diagnostic radiology.
2. Application of information on cerebral function
and metabolism in clinical diagnosis
A method to obtain information on cerebral func-
tion and metabolic change was proposed even with
an MRI device of 1.5T. In a high magnetic field, it
is better to acquire information on function andmeta-
bolic change due through the increased S/N ratio,
improvement in frequency resolution, and so on.
Furthermore the examination time can be short-
ened by increasing the S/N ratio and an additional
measurement for functional of metabolic examina-
tion can be afforded. This aspect brought about by
high magnetic MRI has significant importance, es-
pecially in the clinical setting where time is dis-
tinctly limited. The purposes to add information
on function and metabolism in clinical diagnosis
can be divided roughly into the following :
1) The time when the lesion or abnormality in the
brain is known :
The choice of therapy or the therapeutic plan
will be improved by understanding the back-
ground and mechanism of the disease using
functional or metabolic information derived from
MRI. In addition, it is considered meaningful that
such information will facilitate a prognosis predic-
tion including the severity of the disease and the
curative effects.
2) The time when the lesion or abnormality in the
brain isn’t clear :
Identification of the area or range of disease
may be detected by functional or metabolic infor-
mation and it will be useful to perform a differen-
tial diagnosis.
Although these two purposes cannot be distin-
guished strictly in the actual clinical setting, this
classification is thought to provide a standard to
add functional and metabolic information to ana-
tomical information to facilitate easy understand-
Fig. 1 : The utility of the “Propeller Technique” in an unstable
subject with central neurocytoma
(a) conventional FLAIR image
(b) FLAIR image acquired with the Propeller Technique
(c) T2-WI acquired with the Propeller Technique
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ing. Here, typical examples are introduced to help
understand how to use the functional or metabolic
information.
3) A case of the evaluation of functional andmetabolic
changes in MELAS :
A T2-WI and T1-WI of a 4-year-old child are shown
in Figure 2. An abnormal signal can be observed
in the occipital lobe containing the visual cortex
and the surroundings of the central fissure of the
primary motor area. This lesion showed a rather
high intensity on diffusion-weighted imaging and
hyperperfusion on FAIR imaging, which is one of
the spin labeling perfusionMRI techniques (Figure 3).
Proton MRS was measured by setting a region
of interest (ROI) in the lesion showing abnormal
intensity, revealing the decline of n-acetyl aspar-
tate (NAA) and increase in lactate, and increase in
the signal of macromolecules (MM) in the spec-
trum(Figure 4). It was considered that such signal
changes in each metabolite suggested neuronal
cell damage, an energy metabolism deficiency,
and cellular destruction and necrosis.
From these results, it is considered that patho-
logical changes in MELAS are based on energy
metabolism deficiency in the mitochondria, which
leads to a decreased oxygen utilization, and re-
gional cerebral blood flow is increased by the va-
sogenic reactivity in order to compensate for energy
failure. However, because energy failure does not
occur via a shortage of blood or oxygen, damage
and necrosis of neuronal cells still continues.
Therefore, it can be speculated that the local
peripheral circulation and vasogenic reactivity as a
function of the glial cells still remains at this stage
even though the neuronal cell damage has progressed.
4) A case of multiple sclerosis showing a discrep-
ancy between the symptom and anatomical abnor-
mality on MRI :
The case was a 27-year-old female who had a
past history of multiple sclerosis diagnosis and
therapy, and a new symptom of incomplete paraly-
sis of the right extremities, as shown in Figure 5.
The relapse of multiple sclerosis was suspected and
a brain examination by MRI was conducted. How-
ever, no remarkable new lesion was found on T2-WI
and FLAIR images and a symptomatic cause wasn’t
clear with conventional MRI. The multivoxel
measurement of proton MR spectroscopy, named
Chemical Shift Imaging (CSI), in the brain was
Fig. 3 : Diffusion-weighted images (a) and perfusion-weighted
images (b) of a patient with MELAS
The high intensity on DWI indicates a decrease in water diffu-
sivity reflecting cytotoxic edema. The high intensity area on
perfusion images show high flow rates in the lesion.
Fig. 4 : The ROI setting for acquiring proton MRS (a) and the
obtained spectrum from a patient with MELAS
The increase of lactate and decrease of NAA were revealed in
this spectrum
Fig. 2 : Anatomical images of a patient with MELAS
(a)T2-WI (b)T1-WI
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added following conventional measurement by MRI.
The result of CSI in this case is shown in Figure 6,
and a decrease in NAA and increase in choline
were found in the left hemisphere of the cerebrum
compared to the maintained NAA peak in the right
hemisphere. By constructing a metabolite ratio
map by dividing NAA by Cho, a clear decline in
the NAA/Cho ratio was noted in the left parietal
lobe, as shown in Figure 6.
This result suggested that there was an inflam-
matory lesion in the normal appearing white mat-
ter which could not be recognized as an abnormal
lesion by any conventional imaging modality. It is
reported that the lesion is usually found as the ex-
istence of inflammatory or degeneration by histo-
logical examination, causing symptom or relapse
phenomenon(1).
Even in the lesion which is difficult to identify as
an anatomical abnormality, proton MRS showed
such changes sensitively and with a high de-
tectability of the pathological abnormality. As for
the metabolite map including NAA, the under-
standing of the change is easier when presented
visually, and it is considered that the metabolite
map by the CSI is useful for the detection of nor-
mal appearing white matter.
5) For the routine use of the metabolite map by 3 :
The spectra of proton MRS of 1.5T and 3T in the
same subject, obtained using the same measure-
ment parameters, are shown in Figure 7. The spec-
trum of 3T showed not only a higher S/N ratio but
also a better separation of each signal compared to
1.5T. The characteristics of 3T are a high resolution
and high contrast images brought about by the
increased S/N ratio, leading to a shortening of the
measurement time for routine anatomical exami-
nations. It is also expected that this shortening of the
measurement time will bring about an environ-
ment in which the function or embolic information
are easily added in the daily clinical use.
3. New metabolic information measured by the high
magnetic field
The advantage of 3T is through its ability to detect
a metabolite at a low concentration in tissue which
is usually difficult to observe by 1.5T. Here, the ex-
ample is introduced though the measurement of γ-
aminobutyric acid (GABA), known as an amino acid
related to neurotransmitters.
Glutamate is one of the constituent amino acids
and it isn’t formed only as a neurotransmitter though
there are Glutamate and GABA as an amino acid
which relates to the detectable neurotransmission
by proton MRS. GABA is not a constituent amino
acid and much exists in the neuron. It can be con-
sidered that GABA is more related to neurotrans-
mitters than Glutamate.
However, Glutamate exists about 10mM in the
brain, and only about 1 mM existed in GABA, and
the signal of GABA piled up with the signal of the
metabolite which concentration is high, and more-
over, detailed evaluation was difficult with conven-
tional proton MRS. Therefore, some ways of editing
the signal of GABA selectively were proposed and
we use the J difference method called MEGA-PRESS
which takes the GABA signal at 3.0ppm for 3T MRI
(2). The GABA signal can be recognized compara-
tively clearly in Figure 8 from the region of 27ml
for about 10minutes. A change in the spectrum of
GABA before and after drug administration in a
healthy volunteer is given in Figure 9. On comparison
with before medication, the GABAsignal rose after
two weeks medication with Li which cures depres-
sive psychosis.
As for the intracerebral tubercle with epilepsy, it
Fig. 5 : The anatomical images of a patient with multiple sclerosis.
No remarkable abnormality can be found in these images.(a)T
2-WI (b)High resolution andhigh contrast using the STIR technique
Fig. 6 : Chemical shift imaging of a patient with multiple sclerosis.
(a)typical spectra obtained from the right hemisphere of the
cerebrum ; (b)typical spectra obtained form the left hemi-
sphere of the cerebrum ; (c)NAA/Cho map showing a de-
crease in the NAA/Cho ratio in the left hemisphere of the cere-
brum.
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is recognized that GABA is present at high con-
centration in patients, with tuberous sclerosis in
comparison with the healthy subjects suggesting a
relation with the epileptic insult(3).
Because the relation with the neurotransmitter
is so intimate, GABA is expected to become a new
evaluation index of cerebral function and psychiat-
ric disorder.
4. Establishment of a new diagnostic system for
brain imaging
The number of diseases recognized as causing
functional changes in the brain have recently been
increasing, including obsessive-compulsive disor-
der and autism, and anatomical observation some-
times shows limitations in functional evaluation.
The use of high magnetic field MRI clinically is
thought to provide a good opportunity to evaluate
metabolic or functional changes for practical use.
In the near future, if MRI facilitate a more de-
tailed evaluation of brain function and metabolism,
MRI may substitute positron emission tomogra-
phy and the magnetoencephalogram or be used to
complement these functional measurements.
REFERENCES
1． Chard DT, Griffin CM,McleenMA, Kapeller P,
Kapoor R, Thompson AJ, Miller DH : Brain
metabolite changes in cortical grey and normal
appearing white matter in clinically early re-
lapsing remitting multiple sclerosis. Brain 125:
2342-2352, 2002
2． Mescher M, Merlde H, Kirsch J, Garwood M,
Gruetter R : Simultaneous in vivo spectral
editing and water suppression. NMR Biomed
11 : 266 -272, 1998
3． Asaly J : Proton magnetic resonance spectros-
copy of brain biopsies from patients with intrac-
table epilepsy. Epilepsy Res 35 : 211-217, 1999
Fig. 7 : The difference in spectra between 3T (a) and 1.5T (b). The
signal/noise ratio and resolution of the peaks are markedly dif-
ferent.
Fig. 8 : Typical spectrum measured by MEGA-PRESS showing
the clear observation of GABA
Fig. 9 : GABA signal changes by drug administration
(a)before administration ; (b)after administration
An increase in the GABA peak is clearly observed by drug
administration.
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